Profile of secondary prophylaxis among children with rheumatic heart disease in Alexandria, Egypt

Eastern Mediterranean Health Journal

Volumn 6, Issue 2-3, 2000, Pages 437-446

  Bassili, A ^a   Zaher, S R ^b   Zaki, A ^a   Abdel Fattah, M ^a   Tognoni, G ^c  

^a ALEXANDRIA UNIVERSITY   (Egypt)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CHILD; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EDUCATION; EGYPT; FEMALE; HEALTH; HEALTH CARE QUALITY; HEALTH EDUCATION; HOSPITAL; HUMAN; INFANT; MALE; METHODOLOGY; NEEDS ASSESSMENT; PARENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PRIMARY PREVENTION; PSYCHOLOGICAL ASPECT; RECURRENT DISEASE; RHEUMATIC HEART DISEASE; RISK FACTOR; STANDARD; STATISTICS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EGYPT; FEMALE; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; NEEDS ASSESSMENT; PARENTS; PATIENT COMPLIANCE; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY PREVENTION; QUALITY OF HEALTH CARE; RECURRENCE; RESIDENCE CHARACTERISTICS; RHEUMATIC HEART DISEASE; RISK FACTORS; TREATMENT OUTCOME; URBAN HEALTH;

EID: 0034158224     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Alwan AA. Cardiovascular diseases in the Eastern Mediterranean Region. World health statistics quarterly, 1993, 46:97-100.
2. WHO/CVD unit and principal investigators. WHO programme for the prevention of rheumatic fever/rheumatic heart disease in 16 developing countries: report from Phase I (1986-1990). Bulletin of the World Health Organization, 1992, 70(2):213-8.
3. Sourour AH. Rheumatic fever. A national problem. The need and possibilities for controlling rheumatic fever and rheumatic heart disease. Bulletin of the Egyptian Society of Cardiology, 1981, 20:3-10.
4. Kassem AS et al. Evolution of rheumatic fever in Egyptian children: a fifteen year follow-up study. Egyptian heart journal, 1995, 47(2):79-86.
5. Massell BF et al. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. New England journal of medicine, 1988, 318 (5):280-6.
6. Dajani A et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawazaki disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics, 1995, 96(4 Pt 1):758-64.
7. Rheumatic fever and rheumatic heart disease. Report of a WHO Study Group. Geneva, World Health Organization, 1988:19-21 (WHO Technical Report Series, No. 764).
8. Kassem AS et al. Benzathine penicillin for rheumatic fever prophylaxis: 2-weekly versus 4-weekly regimens. In-dian journal of pediatrics, 1992, 59(6):741-8.
9. Kassem AS et al. Rheumatic fever prophylaxis using benzathine penicillin G (BPG): two-week versus four-week regimens: comparison of two brands of BPG. Pediatrics, 1996, 97(6 Pt 2):992-5.
10. Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special writing group of the Committee on Rheumatic Fever, Endocarditis, and Kawazaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association. Journal of the American Medical Association, 1992, 268(15): 2069-73.
11. Bisno AL. The resurgence of acute rheumatic fever in the United States. Annual review of medicine, 1990, 41:319-29.
12. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the inter-mountain area of the United States. Journal of pediatrics, 1994, 124:9-16.
13. Starfield B. Primary care: participants or gatekeepers? Diabetes care, 1994, 17(1):12-7.
14. Wood HF et al. Rheumatic fever in children and adolescents. A long-term epidemiological study of subsequent prophylaxis, streptococcal infections, and clinical sequelae. III. Comparative effectiveness of three prophylaxis regimens in preventing streptococcal infections and rheumatic recurrences. Annals of internal medicine, 1964, 60(2):31-46.
15. Kumar R et al. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India. Indian heart journal, 1997, 49(3):282-8.
16. Macedo A et al. Cardiopatia reumática na criança. Estudo comparative em dois periodos sucessivos de nove anos. [Rheumatic cardiopathy in children. A comparative study in 2 consecutive 9-year periods.] Acta medica portuguesa, 1989;2(3):127-31.
17. Naim M et al. Rheumatic fever and rheumatic heart disease at the department of Child Health, School of Medicine, University of North Sumatera/Dr Pirngadi Hospital, Medan (1983-1985). Paediatrica indonesiana, 1989, 29(3-4):64-71.
18. McLaren MJ, Markowitz M, Gerber MA. Rheumatic heart disease in developing countries: the consequence of inadequate prevention. Annals of Internal medicine, 1994, 120(3):243-5.
19. Bach JF et al. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet, 1996, 347(9002):644-8.
20. Arguedas A, Mohs E. Prevention of rheumatic fever in Costa Rica. Journal of pediatrics, 1992, 121(4):569-72.